Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: Potential impact of dietary fat quality

Proceedings of the Nutrition Society

Volumn 74, Issue 1, 2015, Pages 67-82

  McMorrow, Aoibheann M ^a   Connaughton, Ruth M ^a   Lithander, Fiona E ^b   Roche, Helen M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF CANBERRA   (Australia)

Author keywords

Adipogenesis; Adipose tissue; Childhood obesity; Fatty acids; Metabolic health

Indexed keywords

MATRIX METALLOPROTEINASE; DIETARY FATS;

ADIPOGENESIS; ADIPOSE TISSUE; ADOLESCENT DISEASE; ARTICLE; BODY MASS; CHILDHOOD OBESITY; DYSLIPIDEMIA; ENERGY BALANCE; EXTRACELLULAR MATRIX; FAT INTAKE; GLUCOSE HOMEOSTASIS; HUMAN; HYPOXIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID STORAGE; LIPOTOXICITY; METABOLIC DISORDER; PANCREAS ISLET BETA CELL; PHENOTYPE; PREGNANCY; SKELETAL MUSCLE; SUBCUTANEOUS FAT; ADOLESCENT; CHILD; DIETARY FATS; HUMANS; METABOLISM; PEDIATRIC OBESITY; PHYSIOLOGY; PHYSIOPATHOLOGY;

ADIPOGENESIS; ADOLESCENT; CHILD; DIETARY FATS; HUMANS; PEDIATRIC OBESITY; SUBCUTANEOUS FAT;

EID: 84921467390     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S002966511400158X     Document Type: Article

References (202)

1. Cole TJ, Freeman JV & Preece MA (1995) Body mass index reference curves for the UK, 1990. Arch Dis Child 73, 25-29.
2. Anderson SE, Economos CD & Must A (2008) Active play and screen time in US children aged 4 to 11 years in relation to sociodemographic and weight status characteristics: a nationally representative cross-sectional analysis. BMC Public Health 8, 366.
3. Savage JS, Mitchell DC, Smiciklas-wright H et al. (2008) Plausible reports of energy intake may predict body mass index in pre-Adolescent girls. J Am Diet Assoc 108, 131-135.
4. Bhargava SK, Sachdev HS, Fall CHD et al. (2004) Serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350, 865-875.
5. Forsen T, Eriksson J, Tuomilehto J et al. (2000) Article the fetal and childhood growth of persons who develop Type 2 diabetes. Ann Intern Med 133, 176-182.
6. Eriksson JG, Tuomilehto J, Osmond C et al. (2001) Early growth and coronary heart disease in later life: longitudinal study. Br J Med 322, 949-953.
7. Tirosh A, Shai I, Afek A et al. (2011) Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med 364, 1315-1325.
8. Jeffreys M, Smith GD, Martin RM et al. (2004) Childhood body mass index and later cancer risk: a 50-year follow-up of the Boyd Orr study. Int J Cancer 112, 348-351.
9. Renehan AG, Tyson M, Egger M et al. (2008) Body-mass index and incidence of cancer: a systematic review and meta-Analysis of prospective observational studies. Lancet 371, 569-578.
10. Salonen MK, Kajantie E, Osmond C et al. (2009) Childhood growth and future risk of the metabolic syndrome in normal-weight men and women. Diab Metab 35, 143-150.
11. Gardner DSL, Hosking J, Metcalf BS et al. (2009) Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (EarlyBird 36). Pediatrics 123, e67-e73.
12. Lloyd LJ, Langley-Evans SC & McMullen S (2012) Childhood obesity and risk of the adult metabolic syndrome: a systematic review. Int J Obes (Lond) 36, 1-11.
13. Juonala M, Magnussen CG, Berenson GS et al. (2011) Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med 365, 1876-1885.
14. Invitti C, Guzzaloni G, Gilardini L et al. (2002) Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diab Care 26, 118-124.
15. Sinha R, Fisch G, Teague B et al. (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346, 802-810.
16. Tershakovec AM, Kuppler KM, Zemel BS et al. (2003) Body composition and metabolic factors in obese children and adolescents. Int J Obes Relat Metab Disord 27, 19-24.
17. Ferguson M, Gutin B, Owens S et al. (1998) Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 67, 1136-1140.
18. Maffeis C, Manfredi R, Trombetta M et al. (2008) Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. J Clin Endocrinol Metab 93, 2122-2128.
19. Ho M, Garnett SP, Baur L et al. (2012) Effectiveness of lifestyle interventions in child obesity: systematic review with meta-Analysis. Pediatrics 130, e1647-e1671.
20. McGovern L, Johnson JN, Paulo R et al. (2008) Clinical review: treatment of pediatric obesity: a systematic review and meta-Analysis of randomized trials. J Clin Endocrinol Metab 93, 4600-4605.
21. Rolland-Cachera MF, Thibault H et al. (2004) Massive obesity in adolescents: dietary interventions and behaviours associated with weight regain at 2 y follow-up. Int J Obes Relat Metab Disord 28, 514-519.
22. Gately P, Cooke C, Butterfly R et al. (2000) The effects of a children's summer camp programme on weight loss , with a 10 month follow-up. Int J Obes 24, 1445-1453.
23. Perreault M, Zulyniak MA, Badoud F et al. (2014) A distinct fatty acid profile underlies the reduced inflammatory state of metabolically healthy obese individuals. PLoS ONE 9, e88539.
24. Pietiläinen KH, Róg T, Seppänen-Laakso T et al. (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9, e1000623.
25. Klein-Platat C, Drai J, Oujaa M et al. (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82, 1178-1184.
26. Aeberli I, Molinari L, Spinas G et al. (2006) Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. Am J Clin Nutr 84, 748-755.
27. Rump P, Popp-Snijders C, Heine R et al. (2002) Components of the insulin resistance syndrome in seven-year-old children: relations with birth weight and the polyunsaturated fatty acid content of umbilical cord plasma phospholipids. Diabetologia 45, 349-355.
28. Korotkova M (2002) Leptin levels in rat offspring are modified by the ratio of linoleic to alpha-linolenic acid in the maternal diet. J Lipid Res 43, 1743-1749.
29. Siemelink M, Verhoef A, Dormans J et al. (2002) Dietary fatty acid composition during pregnancy and lactation in the rat programs growth and glucose metabolism in the offspring. Diabetologia 45, 1397-1403.
30. Oosting A, Kegler D & Beek E (2010) N-3 long-chain polyunsaturated fatty acids prevent excessive fat deposition in adulthood in a mouse model of postnatal nutritional programming. Pediatr Res 68, 494-499.
31. Priego T, Sánchez J, García AP et al. (2013) Maternal dietary fat affectsmilk fatty acid profile and impacts onweight gain and thermogenic capacity of suckling rats. Lipids 48, 481-495.
32. Muhlhausler BS, Gibson RA & Makrides M (2010) Effect of long-chain polyunsaturated fatty acid supplementation during pregnancy or lactation on infant and child body composition: a systematic review. Am J Clin Nutr 92, 857-863.
33. Belzung F, Raclot T & Groscolas R (1993) Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol -Regul Integr Comp Physiol 264, R1111-R1118.
34. OkunoM, Kajiwara K, Imai S et al. (1997) Biochemical and molecular roles of nutrients Perilla oil prevents the excessive growth of visceral adipose tissue in rats by down-regulating adipocyte differentiation 1 J Nutr 127, 1752-1757.
35. Raclot T & Oudart H (1999) Selectivity of fatty acids on lipid metabolism and gene expression. Proc Nutr Soc 58, 633-646.
36. Sun C, Wei Z & Li Y (2011) DHA regulates lipogenesis and lipolysis genes in mice adipose and liver. Mol Biol Rep 38, 731-737.
37. Massiera F, Saint-Marc P, Seydoux J et al. (2003) Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern J Lipid Res 44, 271-279.
38. Nobili V, Bedogni G, Alisi A et al. (2011) Docosahexaenoic acid supplementation decreases liver fat content in children with non-Alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch Dis Child 96, 350-353.
39. Dangardt F, Osika W, Chen Y et al. (2010) Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents. Atherosclerosis 212, 580-585.
40. Dangardt F, Chen Y, Gronowitz E et al. (2012) High physiological omega-3 Fatty Acid supplementation affects muscle Fatty Acid composition and glucose and insulin homeostasis in obese adolescents. J Nutr Metab 2012, 395757.
41. Rytter D, Bech BH, Halldorsson T et al. (2013) No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated with cardiometabolic risk in the 20-year-old offspring. Br J Nutr 110, 2037-2046.
42. Rytter D, Bech BH, Christensen JH et al. (2011) Intake of fish oil during pregnancy and adiposity in 19-y-old offspring: follow-up on a randomized controlled trial. Am J Clin Nutr 94, 701-708.
43. Rytter D, Schmidt EB, Bech BH et al. (2011) Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids 46, 1091-1099.
44. Pittaluga E, Vernal P, Llanos A et al. (2011) Benefits of supplemented preterm formulas on insulin sensitivity and body composition after discharge from the neonatal intensive care unit. J Pediatr. 159, 926-932. e2.
45. Kennedy K, Ross S, Isaacs EB et al. (2010) The 10-year follow-up of a randomised trial of long-chain polyunsaturated fatty acid supplementation in preterm infants: effects on growth and blood pressure. Arch Dis Child 95, 588-595.
46. López-Alarcón M, Martínez-Coronado A, Velarde-Castro O et al. (2011) Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children. Arch Med Res 42, 502-508.
47. Pedersen MH, Mølgaard C, Hellgren LI et al. (2011) The effect of dietary fish oil in addition to lifestyle counselling on lipid oxidation and body composition in slightly overweight teenage boys. J Nutr Metab 2011, 348368.
48. Velázquez-López L, Santiago-Díaz G, Nava-Hernández J et al. (2014) Mediterranean-style diet reduces metabolic syndrome components in obese children and adolescents with obesity. BMC Pediatr 14, 175.
49. Gibney MJ & Walsh MC (2013) The future direction of personalised nutrition: my diet, my phenotype, my genes. Proc Nutr Soc 72, 219-225.
50. Desai M, Beall M & Ross MG (2013) Developmental origins of obesity: programmed adipogenesis. Curr Diab Rep 13, 27-33.
51. Jo J, Gavrilova O, Pack S et al. (2009) Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 5, e1000324.
52. Arner E, Westermark PO, Spalding KL et al. (2010) Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59, 105-109.
53. Virtue S & Vidal-Puig A (2008) It's not how fat you are, it's what you do with it that counts. PLoS Biol 6, e237.
54. Virtue S & Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome -An allostatic perspective. Biochim Biophys Acta 1801, 338-349.
55. Lacasa D, Taleb S & Keophiphath M (2007) Macrophagesecreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148, 868-877.
56. Naukkarinen J, Heinonen S, Hakkarainen A et al. (2014) Characterising metabolically healthy obesity in weightdiscordant monozygotic twins. Diabetologia 57, 167-176.
57. Gray SL & Vidal-Puig AJ (2007) Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev 65, Pt 2, S7-S12.
58. Weiss R, Dufour S, Taksali SE et al. (2003) Prediabetes in obese youth: a syndrome of impaired glucose tolerance , severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362, 951-957.
59. Taksali SE, Caprio S, Dziura J et al. (2008) High visceral and low abdominal subcutaneous fat stores in the obese adolescent. Diabetes 57, 367-371.
60. Kursawe R, Eszlinger M, Narayan D et al. (2010) Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 59, 2288-2296.
61. Kursawe R, Caprio S, Giannini C et al. (2013) Decreased transcription of ChREBP-/ isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes 62, 837-844.
62. Després J-P & Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444, 881-887.
63. Wernstedt Asterholm I, Tao C, Morley TS et al. (2014) Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 20, 103-118.
64. Avram MM, Avram AS & James WD (2007) Subcutaneous fat in normal and diseased states Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol 56, 472-492.
65. Li J, Takaishi K, CookWet al. (2003) Insig-1 'brakes' lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc Natl Acad Sci USA 100, 9476-9481.
66. Rosen ED & Spiegelman BM (2014) What we talk about when we talk about fat. Cell 156, 20-44.
67. Rydén M &Arner P (2007) Tumour necrosis factor-Alpha in human adipose tissue -from signalling mechanisms to clinical implications. J Intern Med 262, 431-438.
68. Medina-Gomez G, Gray SL, Yetukuri L et al. (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3, e64.
69. Kim J, Van De Wall E , Laplante M et al. (2007) Obesity-Associated improvements in metabolic profile through expansion of adipose tissue. 117, 2621-2637.
70. Barroso I, Gurnell M, Crowley VE et al. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880-883.
71. Gray SL, Nora ED, Grosse J et al. (2006) Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-Activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55, 2669-2677.
72. Suzawa M, Takada I, Yanagisawa J et al. (2003) Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 5, 224-230.
73. Sun K, Tordjman J, Clément K et al. (2013) Fibrosis and adipose tissue dysfunction. Cell Metab 18, 470-477.
74. Kubo Y, Kaidzu S, Nakajima I et al. (2014) Organization of extracellular matrix components during differentiation of adipocytes in long-term culture. Vitr Cell Dev Biol 36, 38-44.
75. Nakajima I, Muroya S, Tanabe R et al. (2002) Extracellular matrix development during differentiation into adipocytes with a unique increase in type V and VI collagen. Biol Cell 94, 197-203.
76. Pasarica M, Gowronska-Kozak B, Burk D et al. (2009) Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab 94, 5155-5162.
77. Park J, Morley TS & Scherer PE (2013) Inhibition of endotrophin, a cleavage product of collagen VI, confers Cisplatin sensitivity to tumours. EMBO Mol Med 5, 935-948.
78. Khan T, Muise ES, Iyengar P et al. (2009) Metabolic dysregulation and adipose tissue fibrosis: role of Collagen VI. Mol Cell Biol 29, 1575-1591.
79. Tam CS, Tordjman J, Divoux A et al. (2012) Adipose tissue remodeling in children: the link between collagen deposition and age-related adipocyte growth. J Clin Endocrinol Metab 97, 1320-1327.
80. Sun K, Kusminski CM & Scherer PE (2011) Review series adipose tissue remodeling and obesity. J Clin Invest 121, 2094-2101.
81. Lijnen HR (2002) Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 22, 374-379.
82. Bouloumie A, Sengene C, Portolan G et al. (2001) Adipocyte produces matrix metalloproteinases 2 and Diabetes 50, 2080-2086.
83. Chun T-H, Hotary KB, Sabeh F et al. (2006) A pericellular collagenase directs the 3-Dimensional development of white adipose tissue. Cell 125, 577-591.
84. Krishnan J, Danzer C, Simka T et al. (2012) Dietary obesity-Associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+system. Genes Dev 26, 259-270.
85. Fontana L, Eagon JC, Trujillo ME et al. (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56, 4-7.
86. Bruun JM, Lihn AS, Pedersen SB et al. (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90, 2282-2289.
87. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444, 860-867.
88. Fried SK, Bunkin D A & Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847-850.
89. Hotamisligil GS, Shargill NS & Spiegelman BM (1993). Adipose expression of tumor necrosis factor-Alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
90. McArdle MA, Finucane OM, Connaughton RM et al. (2013) Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) 4, 1-23.
91. Corgosinho FC, de Piano A, Sanches PL et al. (2012) The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome. Inflammation 35, 944-951.
92. Herder C, Schneitler S, Rathmann W et al. (2007) Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92, 4569-4574.
93. Kamchybekov U, Figulla HR, Gerdes N et al. (2012) Macrophage migration inhibitory factor is elevated in obese adolescents. Arch Physiol Biochem 118, 204-209.
94. Stelzer I, Zelzer S, Raggam RB et al. (2012) Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res 159, 118-124.
95. Gual P, Le Marchand-Brustel Y & Tanti J-F (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99-109.
96. Schenk S, Saberi M & Olefsky JM (2008) Insulin sensitivity: modulation by nutrients and inflammation. J Clin Investig 118, 2992-3002.
97. Cali AMG, De Oliveira AM, Kim H et al. (2009) Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link Hepatology 49, 1896-1903.
98. D'Adamo E, Cali AMG, Weiss R et al. (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diab Care 33, 1817-1822.
99. SantoroN,FeldsteinAE,EnokssonEet al. (2013)The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants. Diab Care 36, 1353-1360.
100. D'Adamo E, Marcovecchio ML, Giorgis T de et al. (2013) Pediatric nonalcoholic fatty liver disease, hot topics in endocrine and endocrine-related diseases. M Fedele (ed.). Available from: http://www.intechopen.com/books/hot-topics-in-endocrine-And-endocrine-related-Diseases/pediatric-nonalcoholic-fatty-liver-Disease.
101. Shimomura I, Matsuda M, Hammer RE et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6, 77-86.
102. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A et al. (2008) Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 7, 496-507.
103. Fabbrini E, Sullivan S & Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679-689.
104. Burgert TS, Taksali SE, Dziura J et al. (2006) Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 91, 4287-4294.
105. Sinha R, Dufour S, Petersen KF et al. (2002) Assessment of skeletal muscle triglyceride content by 1H nuclear magnetic resonance spectroscopy in lean and obese adolescents relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51, 1022-1027.
106. Weiss R & Caprio S (2005) The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 19, 405-419.
107. Sabin MA, Stewart CEH, Crowne EC et al. (2006) Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. J Cell Physiol 211, 244-252.
108. Giannini C & Caprio S (2013) Progression of -cell dysfunction in obese youth. Curr Diab Rep 13, 89-95.
109. Weiss R, Caprio S, Trombetta M et al. (2005) Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54, 1735-1743.
110. Meier JJ & Bonadonna RC (2013) Role of reduced -cell mass versus impaired -cell function in the pathogenesis of type 2 diabetes. Diab Care 36, Suppl. 2, S113-S119.
111. Robertson RP & Harmon JS (2006) Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41, 177-184.
112. Donath MY & Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11, 98-107.
113. National Institute for Health and Care Excellence (NICE) (2013) ManagingOverweight and ObesityAmong Children and Young People: LifestyleWeight Management Services, pp. 1-117.
114. Bradley RL, Fisher FFM & Maratos-Flier E (2008) Dietary fatty acids differentially regulate production of TNF-Alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity 16, 938-944.
115. Reynolds CM, McGillicuddy FC, Harford K a et al. (2012) Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol Nutr Food Res 56, 1212-1222.
116. Kalupahana NS, Claycombe K, Newman SJ et al. (2010) Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 140, 1915-1922.
117. Muhlhausler BS, Cook-Johnson R, James M et al. (2010). Opposing effects of omega-3 and omega-6 long chain polyunsaturated Fatty acids on the expression of lipogenic genes in omental and retroperitoneal adipose depots in the rat. J Nutr Metab 2010, 1-9.
118. Raclot T, Groscolas R, Langin D et al. (1997) Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38, 1963-1972.
119. Azain MJ (2004) Role of fatty acids in adipocyte growth and development. J Anim Sci 82, 916-924.
120. Raz A, Kamin-Belsky N, Przedecki F et al. (1997) Fish oil inhibits A6 desaturase activity in vivo: utility in a dietary paradigm to obtain mice depleted of arachidonic acid. Nutr Biochem 2863, 558-565.
121. Cameron N & Demerath E (2002) Critical periods in human growth and their relationship to diseases of aging. Yearb Phys Anthropol 45, 159-184.
122. Tarantal AF & Berglund L (2014) Obesity and lifespan health -importance of the fetal environment. Nutrients 6, 1725-1736.
123. Poissonnet CM, Burdi AR & Garn SM (1984) The chronology of adipose tissue appearance and distribution in the human fetus. Early Hum Dev 10, 1-11.
124. Billon N & Dani C (2012) Developmental origins of the adipocyte lineage: new insights from genetics and genomics studies. Stem Cell Rev Rep 8, 55-66.
125. Baker GL (1969) Human adipose tisue compositon and age. Am J Clin Nutr 22, 829-835.
126. Kuipers RS, Luxwolda MF, Offringa PJ et al. (2012) Gestational age dependent content, composition and intrauterine accretion rates of fatty acids in fetal white adipose tissue. Prostaglandins Leukot Essent Fat Acids 86, 39-49.
127. Olhager E, Flinke EVA, Hannerstad ULF et al. (2003) Studies on human body composition during the first 4 months of life using magnetic resonance imaging and isotope dilution. Pediatr Res 54, 906-912.
128. Verkauskiene R, Beltrand J, Claris O et al. (2007) Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age. Eur J Endocrinol 157, 605-612.
129. Wu G, Bazer FW, Cudd TA et al. (2004) Maternal nutrition and fetal development. J Nutr 134, 2169-2172.
130. Masuyama H & Hiramatsu Y (2012) Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology 153, 2823-2830.
131. Sarr O, Yang K & Regnault TRH (2012). In utero programming of later adiposity: the role of fetal growth restriction. J Pregnancy 2012, 1-10.
132. Lapillonne A, Braillon P, Pg C et al. (1997) Body composition in appropriate and in small for gestational age infants. Acta Paediatr 86, 196-200.
133. Godfrey KM & Barker DJ (2000) Fetal nutrition and adult disease. Am J Clin Nutr 71, 5 Suppl., 1344S-1352S.
134. Shepherd PR, Crowther NJ, Desai M et al. (1997) Altered adipocyte properties in the offspring of protein malnourished rats. Br J Nutr 78, 121-129.
135. Díaz M, Bassols J, Aragonés G et al. (1997) Decreased placental expression of pre-Adipocyte factor-1 in children born small-for-gestational-Age: association to early postnatal weight gain. Placenta 34, 331-334.
136. De Zegher F, Lopez-Bermejo A & Ibáñez L (2009) Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol Metab 20, 418-423.
137. Bouhours-Nouet N, Dufresne S, Boux De Casson F et al. (2008) High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance. Diab Care 31, 1031-1036.
138. Harder T, Rodekamp E, Schellong K et al. (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-Analysis. Am J Epidemiol 165, 849-857.
139. Whincup PH, Kaye SJ, Owen CG et al. (2008) Birth weight and risk of type 2 diabetes: a systematic review. J Am Med Assoc 300, 2886-2897.
140. Lee Y-H, Mottillo EP & Granneman JG (2013) Adipose tissue plasticity from WAT to BAT and in between. Biochim Biophys Acta. 1842, 358-369.
141. Guénard F, Deshaies Y, Cianflone K et al. (2013) Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci USA 110, 11439-11444.
142. Smith J, Cianflone K, Biron S et al. (2009) Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab 94, 4275-4283.
143. Quinlivan J a, Julania S & Lam L (2011) Antenatal dietary interventions in obese pregnant women to restrict gestational weight gain to Institute of Medicine recommendations. Obstet Gynecol 118, 1395-1401.
144. Gallou-Kabani C, Vigé A, Gross M-S et al. (2007) Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods. Am J Physiol Endocrinol Metab 292, E1095-E1100.
145. Rodríguez G, Iglesia I, Bel-Serrat S et al. (2012) Effect of n-3 long chain polyunsaturated fatty acids during the perinatal period on later body composition. Br J Nutr 107, Suppl., S117-S128.
146. Much D, Brunner S, Vollhardt C et al. (2013) Effect of dietary intervention to reduce the n-6/n-3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age. Eur J Clin Nutr 67, 282-288.
147. Rytter D, Christensen JH, Bech BH et al. (2012) The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19-year-old offspring. Br J Nutr 108, 1475-1483.
148. Salvig JD & Lamont RF (2011) Evidence regarding an effect of marine n-3 fatty acids on preterm birth: a systematic review and meta-Analysis. Acta Obstet Gynecol Scand 90, 825-838.
149. Calder PC, Ahluwalia N, Brouns F et al. (2011) Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 106, Suppl., S5-S78.
150. Hauner H, Brunner S & Amann-gassner U (2013) The role of dietary fatty acids for early human adipose tissue growth. Am J Clin Nutr. 98, 549-555.
151. Kuipers RS, Luxwolda MF, Offringa PJ et al. (2012) intrauterine whole body linoleic, arachidonic and docosahexaenoic acid contents and accretion rates. Prostaglandins Leukot Essent Fatty Acids 86, 13-20.
152. Cristancho AG & Lazar M a (2011) Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12, 722-734.
153. Knittle JL, Timmers KIM, Ginsberg-fellner F et al. (1979) The Growth of Adipose Tissue in Children and Adolescents: Adipose Cell Number and Size. J Clin Investig 63, 239-246.
154. Spalding KL, Arner E, Westermark PO et al. (2008) Dynamics of fat cell turnover in humans. Nature 453, 783-787.
155. Druet C, StettlerN, Sharp S et al. (2012) Prediction of childhood obesity by infancy weight gain: an individual-level meta-Analysis. Paediatr Perinat Epidemiol 26, 19-26.
156. Ekelund U, Ong KK, Linné Y et al. (2007) Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab 92, 98-103.
157. Morrison JL, Duffield J a, Muhlhausler BS et al. (2010) Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatr Nephrol 25, 669-677.
158. Berends LM, Fernandez-Twinn DS, Martin-Gronert MS et al. (2013) Catch-up growth following intra-uterine growth-restriction programmes an insulin-resistant phenotype in adipose tissue. Int J Obes (Lond) 37, 1051-1057.
159. Fabricius-Bjerre S, Jensen RB, Faerch K et al. (2011) Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence. PLoS ONE 6, e20595.
160. Escribano J, Luque V, Ferre N et al. (2012) Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. Int J Obes (Lond) 36, 548-553.
161. De Zegher F, Sebastiani G, Diaz M et al. (2013) Breast-feeding vs formula-feeding for infants born small-for-gestational-Age: divergent effects on fat mass and on circulating IGF-I and high-molecular-weight adiponectin in late infancy. J Clin Endocrinol Metab 98, 1242-1247.
162. De Zegher F, Sebastiani G, Diaz M et al. (2012) Body composition and circulating high-molecular-weight adiponectin and IGF-I in infants born small for gestational age: breast-versus formula-feeding. Diabetes 61, 1969-1973.
163. Gorski JN, Dunn-Meynell AA, Hartman TG et al. (2006) Postnatal environment overrides genetic and prenatal factors influencing offspring obesity and insulin resistance. Am J Physiol Regul Integr Comp Physiol 291, R768-R778.
164. Nash A, Secker D, Corey M et al. (2008) Field testing of the 2006 World Health Organization growth charts from birth to 2 years: assessment of hospital undernutrition and overnutrition rates and the usefulness of BMI. J Parenter Enter Nutr 32, 145-153.
165. Plachta-Danielzik S, Bosy-Westphal A, Kehden B et al. (2013) Adiposity rebound is misclassified by BMI rebound. Eur J Clin Nutr 67, 984-989.
166. Rolland-Cachera MF, Deheeger M, Bellisle F et al. (1984) Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr 39, 129-135.
167. Taylor RW,Williams SM, Carter PJ et al. (2011) Changes in fat mass and fat-free mass during the adiposity rebound: FLAME study. Int J Pediatr Obes 6, e243-e251.
168. Wadsworth M, Butterworth S, Marmot M et al. (2005) Early growth and type 2 diabetes: evidence from the 1946 British birth cohort. Diabetologia 48, 2505-2510.
169. Eriksson JG (2011) Early growth and coronary heart disease and type 2 diabetes: findings from the Helsinki Birth Cohort Study (HBCS). Am J Clin Nutr 94, 6 Suppl., 1799S-1802S.
170. Cole TJ (2004) Children grow and horses race: is the adiposity rebound a critical period for later obesity BMC Pediatr 4, 6.
171. Ohlsson C, Lorentzon M, Norjavaara E et al. (2012) Age at adiposity rebound is associated with fat mass in young adult males-The GOOD study. PLoS ONE 7, e49404.
172. González L, Corvalán C, Pereira a et al. (2014) Early adiposity rebound is associated with metabolic risk in 7-yearold children. Int J Obes 38, 1299-1304.
173. Koyama S, Ichikawa G, KojimaMet al. (2014) Adiposity rebound and the development of metabolic syndrome. Pediatrics 133, e114-e119.
174. Pedersen L, Lauritzen L, Brasholt M et al. (2012) Polyunsaturated fatty acid content of mother's milk is associated with childhood body composition. Pediatr Res 72, 631-636.
175. Bergmann LR, Bergmann K, Haschke-Becher E et al. (2007) Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy J Perinat Med 35, 295-300.
176. Rodríguez G,Moreno L, BlayMet al. (2004) Body composition in adolescents: measurements and metabolic aspects. Int J Obes Relat Metab Disord 28, Suppl. 3, S54-S58.
177. Gilsanz V, Smith ML, Goodarzian F et al. (2012) Changes in brown adipose tissue in boys and girls during childhood and puberty. J Pediatr 160, 604-609.
178. Gilsanz V, Hu HH & Kajimura S (2013) Relevance of brown adipose tissue in infancy and adolescence. Pediatr Res 73, 3-9.
179. Rodriguez-Cuenca S, Monjo M, Frontera M et al. (2007) Sex steroid receptor expression profile in brown adipose tissue. Effects of hormonal status. Cell Physiol Biochem 20, 877-886.
180. Hioki C, Yoshida T, Kogure A et al. (2004) Effects of Growth Hormone (GH) on mRNA levels of uncoupling Proteins 1, 2, and 3 in brown and white adipose tissues and skeletalmuscle in obesemice. HormMetab Res 36, 607-613.
181. Goran M & Gower B (2001) Longitudinal study on pubertal insulin resistance. Diabetes 50, 2444-2450.
182. Bloch C, Clemons P & Sperling M (1987) Puberty decreases insulin sensitivity. J Pediatr 110, 481-487.
183. Kelly L, Lane C, Weigensberg M et al. (2011) Pubertal changes of insulin sensitivity, acute insulin response, and -cell function in overweight Latino youth. J Pediatr 158, 442-446.
184. Janiszewski PM & Ross R (2010) Effects of weight loss among metabolically healthy obese men and women. Diab Care 33, 1957-1959.
185. Liu RH, Wharton S, Sharma AM et al. (2013) Influence of a clinical lifestyle-based weight loss program on the metabolic risk profile of metabolically normal and abnormal obese adults. Obesity 21, 1533-1539.
186. Baer DJ, Judd JT, Clevidence B a et al. (2004) Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 79, 969-973.
187. Nguyen MTA, Favelyukis S, Nguyen A-K et al. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-Dependent pathways. J Biol Chem 282, 35279-35292.
188. Cypess AM & Kahn CR (2010) The role and importance of brown adipose tissue in energy homeostasis. Curr Opin Pediatr 22, 478-484.
189. Nedergaard J, Bengtsson T & Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293, E444-E452.
190. Saito M, Okamatsu-ogura Y, Matsushita M et al. (2009) High incidence of metabolically active brown adipose effects of cold exposure and adiposity. Diabetes 58, 1526-1531.
191. Zingaretti MC, Crosta F, Vitali A et al. (2009) The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 23, 3113-3120.
192. Hamann A, Flier J & Lowell B (1996) Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137, 21-29.
193. Feldmann HM, Golozoubova V, Cannon B et al. (2009) UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 9, 203-209.
194. Lee P, Swarbrick MM, Zhao JT et al. (2011) Inducible brown adipogenesis of supraclavicular fat in adult humans. Endocrinology 152, 3597-3602.
195. Oudart H, Groscolas R, Calgari C et al. (1997) Brown fat thermogenesis in rats fed high-fat diets enriched with n-3 polyunsaturated fatty acids. Int J Obes Relat Metab Disord 21, 955-962.
196. Oi-Kano Y, Kawada T, Watanabe T et al. (2007) Extra virgin olive oil increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. J Nutr Biochem 18, 685-692.
197. Oi-Kano Y, Kawada T, Watanabe T et al. (2008) Oleuropein, a phenolic compound in extra virgin olive oil, increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. J Nutr Sci Vitaminol (Tokyo) 54, 363-370.
198. Bouwman J, Vogels JT, Wopereis S et al. (2012) Visualization and identification of health space, based on personalized molecular phenotype and treatment response to relevant underlying biological processes. BMC Med Genomics 5, 1.
199. Gilardini L, Pasqualinotto L, Croci M et al. (2012) Obese children with normal insulin sensitivity respond differently from those with insulin resistance to lifestyle modifications. Public Health Nutr 15, 1536-1537.
200. Moleres A, Campión J, Milagro FI et al. (2013) Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J 27, 2504-2512.
201. Phillips CM, Dillon C, Harrington JM et al. (2013) Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS ONE 8, e76188.
202. Van Ommen B, Keijer J, Kleemann R et al. (2008) The challenges for molecular nutrition research 2: quantification of the nutritional phenotype. Genes Nutr 3, 51-59.